Results 11 to 20 of about 41,188 (289)

Cerebral salt wasting in a patient with myeloproliferative neoplasm [PDF]

open access: greenBMC Neurology, 2019
Background Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma.
Lea Orlik   +3 more
doaj   +2 more sources

Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis [PDF]

open access: yes, 2018
Background. The knowledge of natural history of patients with portal hypertension (PH) not due to cirrhosis is less well known than that of cirrhotic patients. Aim.
Aprile, Francesca   +7 more
core   +1 more source

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation

open access: yesSAGE Open Medical Case Reports, 2021
The entity myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome is characterized by the coexistence of both myeloproliferative and myelodysplastic features in the bone marrow.
Anette Lodvir Hemsing   +4 more
doaj   +1 more source

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? [PDF]

open access: yes, 2019
Porto sinusoidal vascular liver disease (PSVD) and portal vein thrombosis (PVT) are distinct vascular liver diseases characterized, respectively, by an intrahepatic and a prehepatic obstacle to the flow in the liver portal system. PVT may also occur as a
D'Amati, G.   +4 more
core   +1 more source

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate

open access: yesHaematologica, 2014
Clinical significance of the JAK2V617F mutation in patients with a myeloproliferative neoplasm has been the target of intensive research in recent years. However, there is considerably uncertainty about prognosis in JAK2V617F positive individuals without
Camilla Nielsen   +4 more
doaj   +1 more source

Myelodysplastic/Myeloproliferative Neoplasm in a Dog: A Case Report. [PDF]

open access: yesVet Med Sci
This is a bone marrow aspirate smear image from an 18‐year‐old mixed‐breed dog diagnosed with myelodysplastic/myeloproliferative neoplasm. Both peripheral blood and bone marrow examinations revealed marked myeloid hyperplasia and dysplastic changes. ABSTRACT Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) is a clonal myeloid disorder ...
Cha S, Yu D, Bae H.
europepmc   +2 more sources

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients

open access: yesHaematologica, 2011
Within a cohort of 1,915 consecutive patients with myeloproliferative neoplasm followed for a median time of 5.2 years (range 0–33.3), we investigated the occurrence of lymphoid neoplasm with the aim of defining this risk and to investigate the role of ...
Elisa Rumi   +9 more
doaj   +1 more source

Extracranial carotid artery aneurysm with myeloproliferative neoplastic cell invasion

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2020
The major causes of rare extracranial carotid artery aneurysms are arteriosclerosis, trauma, and radiation therapy. Here, we describe a patient with an extracranial carotid artery aneurysm caused by a myeloproliferative neoplasm.
Shotaro Ogawa, MD   +2 more
doaj   +1 more source

IL-4 Serum Level Estimation in Myeloproliferative Neoplasm Patients

open access: yesمجلة مركز بحوث التقنيات الاحيائية, 2022
Back Ground: Myeloproliferative neoplasm (MPN) is a long-term blood disease that has an excess production of mature hematopoietic pluripotent stem cells in the bone marrow. In the early fifties, W.
Ahmed Rushdi Abdullah
doaj   +1 more source

Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort

open access: yesHaematologica, 2019
Myeloid and lymphoid malignancies are postulated to have distinct pathogenetic mechanisms. The recent observation that patients with a myeloproliferative neoplasm have an increased risk of developing lymphoproliferative malignancy has challenged this ...
Johanne M. Holst   +23 more
doaj   +1 more source

Home - About - Disclaimer - Privacy